RADAY GILEAD (Chief Operating Officer) sold 5.7% of their position (15.74M shares) of REDHILL BIOPHARMA LTD. on the open market
Open‑market sale worth $1.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 4/22/2026ACC: 0001178913-26-002183
Officer· Chief Operating Officer
Since Mar 2026
+15.04M
Net shares
Net buyer
$1.6K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
30.78M acquired · 15.74M disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−15.74M
Price / share
$0.00
Trade value
$1.57K
% of position
5.7%
4/6/2026
276.80M→261.06M
Total
Net shares
−15.74M
Net value
-$1.57K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/6/2026 | S · Sale | −15.74M | $0.00 | $1.57K | 5.7% | 276.80M | 261.06M |
| Total | −15.74M | -$1.57K | ||||||
Derivative Transactions1
American Depositary Shares
Direct
Converts to
Ordinary Shares
30.78M shares
Shares
+30.78M
Strike price
Held after
76.15M
Exercisable
—
4/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | Ordinary Shares30.78M shares | 4/6/2026 | M · Option Exercise | +30.78M | — | 76.15M |